Production method for nadroparin calcium
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- NANJING KING FRIEND BIOCHEM PHARMA CO LTD
- Publication Date
- 2015-04-22
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The invention relates to the field of biomedicine, in particular to a method for producing nadroparin calcium. Background technique
[0002] Heparin Sodium is a mucopolysaccharide sulfate anticoagulant. Heparin sodium is the sodium salt of aminodextran sulfate extracted from the intestinal mucosa of pigs or cattle, and belongs to mucopolysaccharides. It has anticoagulant effect both in vivo and in vitro, and is currently the mainstream anticoagulant drug. However, the bioavailability of unfractionated heparin is low and the side effects are large. Later, it was discovered that the sodium salt of aminodextran sulfate fragment obtained by cleavage of heparin sodium has an average molecular weight of 4000-6000 Daltons, which is called low molecular weight heparin sodium. Low molecular weight heparin sodium injection, like heparin sodium injection, is an antithrombin Ⅲ (AT Ⅲ) dependent thrombin inhibitor. However, compared with heparin sodium injection,...